XML 9 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure [Line Items]      
Disclosure - Pay vs Performance Disclosure
Pay Versus Performance Table
 

(a)

Year

    

(b)

Summary Compensation Table Total for PEO

($)

    

(c)

Compensation Actually Paid to PEO

($)

    

(d)

Actual Summary Compensation Table Total for Non-PEO Named Executive Officers

($)

    

(e)

Average Compensation Actually Paid to Non-PEO Named Executive Officers

($)

 
 2024    150,000    150,000    384,600    384,600 
 2023    223,800    223,800    379,200    379,200 
 2022    123,000    123,000    261,150    261,150 
   
Named Executive Officers, Footnote [Text Block]

 

·During 2024, our Chief Executive Officer was Michael S. Liebowitz. During 2023, our Chief Executive Officers were Michael A Feinstein, M.D. and Michael S. Liebowitz. During 2022, our Chief Executive Officer was Michael A. Feinstein, M.D.

·During 2024, 2023 and 2022, our remaining NEO’s consisted of Terry W. Stovold, Chief Operating Officer and Mathew C. Winger, Executive Vice President of Corporate Development. Mr. Winger’s appointment to this position was effective on October 1, 2022. The amount reported in Column (e) includes the $125,000 annualized value of Mr. Winger’s base salary in 2022.
   
PEO Total Compensation Amount $ 150,000 $ 223,800 $ 123,000
PEO Actually Paid Compensation Amount 150,000 223,800 123,000
Non-PEO NEO Average Total Compensation Amount 384,600 379,200 261,150
Non-PEO NEO Average Compensation Actually Paid Amount $ 384,600 $ 379,200 $ 261,150
PEO Name Michael S. Liebowitz Michael A Feinstein, M.D. and Michael S. Liebowitz Michael A. Feinstein, M.D